Science & Enterprise subscription

Follow us on Twitter

  • A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that return… https://t.co/kdaawxTrOU
    about 8 hours ago
  • New post on Science and Enterprise: Hospitals Testing Fast Covid-19 Diagnostic https://t.co/Ou6Fk0L4Yb #Science #Business
    about 8 hours ago
  • Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sighte… https://t.co/fJkqvINR8w
    about 15 hours ago
  • New post on Science and Enterprise: Muti-Focus Contact Lenses Slow Children’s Myopia https://t.co/mWV1LNbHOW #Science #Business
    about 15 hours ago
  • Could?? ... How Russia’s Rushed Covid-19 Vaccine Could Backfire https://t.co/Sqt4P3jllE
    about 18 hours ago

Please share Science & Enterprise

Infographic – Apple Leads in A.I. Acquistions

A.I. acquisitions chart

Among the tech giants, Apple is the most aggressive in acquiring start-ups developing A.I. applications over the past 10 years. . . . → Read More: Infographic – Apple Leads in A.I. Acquistions

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Synthetic Bio Cancer Immunotherapy Company Acquired

Natural killer cell

A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired

Synthetic Bio Company Acquired in $2.35B Deal

E. coli bacteria

A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion. . . . → Read More: Synthetic Bio Company Acquired in $2.35B Deal

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Genentech, Biotech Partner on Multiple Sclerosis

Neurons illustration

A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis

Infographic – Top Tech Acquisition Timeline

Top tech industry acquisitions

The world’s five leading technology enterprises are acquiring more companies and with more money in recent years than before. . . . → Read More: Infographic – Top Tech Acquisition Timeline

Educational Robotics Spin-Off Company Acquired

Root tablet and robot

Root Robotics, a developer of robots that teach coding to school children, is now part of the consumer and educational robotics company iRobot Corp. . . . → Read More: Educational Robotics Spin-Off Company Acquired

Venture Funds, Mergers in A.I. Up Sharply in 2018

Glasses, computer screens

Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018

Biogen Acquires Gene Therapy Company in $800M Deal

Eye exam

A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal